JPMORGAN CHASE & CO - ATOSSA THERAPEUTICS INC ownership

ATOSSA THERAPEUTICS INC's ticker is ATOS and the CUSIP is 04962H506. A total of 53 filers reported holding ATOSSA THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.11 and the average weighting 0.0%.

Quarter-by-quarter ownership
JPMORGAN CHASE & CO ownership history of ATOSSA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$69
-41.5%
940.0%0.00%
Q2 2023$118940.0%0.00%
Q1 2023$0940.0%0.00%
Q4 2022$0940.0%0.00%
Q3 2022$0940.0%0.00%
Q2 2022$0
-100.0%
94
-99.8%
0.00%
Q1 2022$69,0000.0%54,960
+27.0%
0.00%
Q4 2021$69,000
-72.8%
43,277
-44.6%
0.00%
Q3 2021$254,000
-74.3%
78,074
-50.1%
0.00%
Q2 2021$988,000
+4390.9%
156,324
+1276.8%
0.00%
Q3 2019$22,00011,3540.00%
Other shareholders
ATOSSA THERAPEUTICS INC shareholders Q2 2023
NameSharesValueWeighting ↓
GSA CAPITAL PARTNERS LLP 347,392$2560.02%
XTX Topco Ltd 167,427$123,3100.02%
Laurion Capital Management LP 2,225,800$1,639,3020.01%
Virtu Financial LLC 80,728$590.01%
LVM CAPITAL MANAGEMENT LTD/MI 21,000$150.00%
Renaissance Technologies 1,242,370$9150.00%
St. Johns Investment Management Company, LLC 1,550$1,1420.00%
Caption Management, LLC 75,000$55,2380.00%
J. L. Bainbridge & Co., Inc. 11,121$8,1910.00%
Connor, Clark & Lunn Investment Management Ltd. 133,591$98,3900.00%
View complete list of ATOSSA THERAPEUTICS INC shareholders